June 16, 2020 / 11:45 AM / 19 days ago

BRIEF-Moleculin Announces Confirmatory In Vitro Analysis Of WP1122

June 16 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ANNOUNCES CONFIRMATORY IN VITRO ANALYSIS OF WP1122

* MOLECULIN BIOTECH INC - ANNOUNCED THAT A REPEAT OF PREVIOUS IN VITRO TESTING HAS CORROBORATED ANTIVIRAL POTENTIAL OF WP1122

* MOLECULIN BIOTECH - RESULTS OF REPEATED ROUND OF IN VITRO TESTING RECEIVED, CONFIRM WP1122 HAS AN ANTIVIRAL EFFECT ON HUMAN CORONAVIRUS 229E

* MOLECULIN BIOTECH - EXPECTS TO FILE REQUEST FOR IND STATUS TO TEST WP1122 FOR TREATMENT OF COVID-19 PATIENTS DURING H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below